Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Major Depressive Disorder Excellence Forum

Major Depressive Disorder
Excellence Forum

Ahmed Baig
Videos
Addressing Depression Symptoms With a Comprehensive Approach
08/06/2023

With Ahmed Baig, MD

With Ahmed Baig, MD
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical...
08/06/2023
Psych Congress Network
Dr Ahmed Baig
Videos
Novel Treatments for MDD and TRD
08/03/2023

With Ahmed Baig, MD

With Ahmed Baig, MD
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical...
08/03/2023
Psych Congress Network
Susan Montgomery, DNP, FNP-BC, and Lauren Sharp, FNP
Videos
Routine Depression Screening Increases Identification, Diagnosis, and Management: Part 2
08/01/2023
Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, share more about findings from their study “Improving Screening for Major Depressive Disorder."
Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, share more about findings from their study “Improving Screening for Major Depressive Disorder."
Susan Mongomery, DNP, FNP-BC,...
08/01/2023
Psych Congress Network
Why are clinicians wary of antipsychotic use in MDD treatment?
Expert Insights Quiz
Why do clinicians tend to underuse antipsychotics in the treatment of MDD?
07/27/2023

With Craig Chepke, MD, DFAPA

With Craig Chepke, MD, DFAPA
Time for a pop quiz!
Time for a pop quiz!
Time for a pop quiz!
07/27/2023
Psych Congress Network
Craig Chepke, MD, DFAPA
Videos
Why Antipsychotics Are Underutilized for Major Depressive Disorder (MDD)
07/25/2023

Featuring Craig Chepke, MD, DFAPA

Featuring Craig Chepke, MD, DFAPA ...
Craig Chepke, MD, DFAPA, shares why he thinks clinicians do not use antipsychotics for MDD treatment as much as they could.
Craig Chepke, MD, DFAPA, shares why he thinks clinicians do not use antipsychotics for MDD treatment as much as they could.
Craig Chepke, MD, DFAPA, shares...
07/25/2023
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Expert Insights Quiz
How can clinicians optimize treatment with subcutaneous racemic ketamine for TRD?
07/25/2023
Put your psychiatry knowledge to the test with this quiz!
Put your psychiatry knowledge to the test with this quiz!
Put your psychiatry knowledge to...
07/25/2023
Psych Congress Network
How many patients accepted depression treatment following diagnosis?
Expert Insights Quiz
How many patients accepted depression treatment following diagnosis?
07/22/2023
Test your knowledge!
Test your knowledge!
Test your knowledge!
07/22/2023
Psych Congress Network
Colleen Loo
Q&As
Ketamine Treatment in TRD Should Last 4 Weeks or More for Antidepressant Benefit
07/21/2023

Featuring Colleen Loo, MBBS, FRANZCP, MD

Featuring Colleen Loo, MBBS, FRANZCP,...
Colleen Loo, MBBS, FRANZCP, MD, lead researcher of a groundbreaking study on the use of subcutaneous racemic ketamine for TRD, shares the rationale behind the study, its major findings, practical implications, and more.
Colleen Loo, MBBS, FRANZCP, MD, lead researcher of a groundbreaking study on the use of subcutaneous racemic ketamine for TRD, shares the rationale behind the study, its major findings, practical implications, and more.
Colleen Loo, MBBS, FRANZCP, MD,...
07/21/2023
Psych Congress Network
Susan Montgomery, DNP, FNP-BC, and Lauren Sharp, FNP
Videos
Routine Depression Screening Increases Identification, Diagnosis, and Management: Part 1
07/21/2023
Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, discuss findings from their study “Improving Screening for Major Depressive Disorder."
Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, discuss findings from their study “Improving Screening for Major Depressive Disorder."
Susan Mongomery, DNP, FNP-BC,...
07/21/2023
Psych Congress Network
Who saw the most improvement in depressive symptoms after physical activity?
Expert Insights Quiz
Who saw the most improvement in depressive symptoms after physical activity?
07/17/2023
Was it children older or younger than 13 years?
Was it children older or younger than 13 years?
Was it children older or younger...
07/17/2023
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement